Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host Disease of the Gastrointestinal Tract
Drew J. Winston(University of California, Los Angeles), Voravit Ratanatharathorn(University of Michigan–Ann Arbor), Werner Lange(La Roche College), Don A. Gabriel(University of North Carolina at Chapel Hill), Yi‐Ju Li(University of Pennsylvania), Lindsey R. Baden(Brigham and Women's Hospital), Christos Emmanouilides(University of California, Los Angeles)
Cited by 71
Related Papers
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k